Published 2 days ago • loading... • Updated 1 day ago

C M Bidwell & Associates Ltd. Invests $351,000 in Gilead Sciences, Inc. (NASDAQ:GILD)

Summary by wkrb13.com

C M Bidwell & Associates Ltd. bought a new stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 3,801 shares of the biopharmaceutical company’s stock, valued at approximately $351,000. Other hedge funds and other institutional investors […]

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All

Left

Center

Right

DirectorsTalk Interviews

Gilead Sciences, Inc. (GILD): A Biopharma Giant with Strong Buy Ratings Amidst Market Volatility

Navigating the complex waters of the biopharmaceutical sector can be challenging for investors, but Gilead Sciences, Inc. (NASDAQ: GILD) stands out as a noteworthy contender, blending robust research capabilities with a diverse portfolio of life-saving drugs. With a market capitalization of $139.68 billion, Gilead is not just a major player in the healthcare industry; it’s a pivotal force driving innovations that address unmet medical needs glob…

1 day ago

Read Full Article